Provided by Tiger Fintech (Singapore) Pte. Ltd.

PATRYS LTD

0.002
0.000
Volume:- -
Turnover:- -
Market Cap:4.73M
PE:-1.33
High:0.002
Open:0.002
Low:0.002
Close:0.002
Loading ...

Company Profile

Company Name:
PATRYS LTD
Exchange:
ASX
Establishment Date:
2006
Employees:
10
Office Location:
96-100 Albert Road,Level 4,Melbourne,Victoria,Australia
Zip Code:
3205
Fax:
61 3 9077 9233
Introduction:
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.